This course provides an overview of first-generation antipsychotic (FGA) and second-generation antipsychotic (SGA) use in BC and Canada as it relates to children and youth. The three modules include a review of current approvals and prescription trends, examine the implications of SGA use and review evidence-informed practices for the monitoring and management of SGAs.